Clearside Biomedical Inc (CLSD NASDAQ) stock market data APIs
$3.8178
-0.11(-2.9%)
as of October 23, 2025
Try our APIs with
free plan!
Clearside Biomedical Inc Financial Data Overview
Price chart is built with
Anychart
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Prev. Close
3.8178
Open
3.7099
High
4.0144
Low
3.6394
52 wk Range
3.32-17.4
Market Cap
19 889 K
Shares Outstanding
5 234 K
Revenue
4 166 K
EPS
-0.1
Beta
2.052
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Clearside Biomedical Inc data using free add-ons & libraries
Get Clearside Biomedical Inc Fundamental Data
Clearside Biomedical Inc Fundamental data includes:
- Net Revenue: 4 166 K
- EBITDA: -21 533 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-18
- EPS/Forecast: -0.1029
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Clearside Biomedical Inc News
New
Biotech Stocks Surge After Hours On Trial Updates And Strategic Moves
(RTTNews) - After-hours trading on Tuesday featured a wave of notable price moves across the biotech and therapeutics space, with several small- and mid-cap names posting sharp gains following clinica...
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX Trial Designs in Wet AMD and Diabetic Retinopathy to ...
Discover the top movers in Thursday's pre-market session.
Wondering what's happening in Thursday's pre-market session? Find an overview in this article. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT SNOA [https://www.chartmill.com/stock/...
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates
Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.1 per share a year ago. These ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
